Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Chemo case studies: How HCWs became exposed

    Both vincristine and doxorubicin and their metabolites have been associated with allergic reactions when given to patients. The aerosolization of the drug present in the urine may have provided enough exposure for symptoms to develop.
  • 'Advances in Cardiovascular Technology Vol. 2’ available

    Advances in Cardiovascular Technology: Emerging Markets for the 21st Century, Vol. 2, the newest sourcebook from the publishers of Cardiovascular Device Update and The BBI Newsletter, is now available.
  • From the Lab

    For a medical disorder affecting more than a quarter-million Americans each year, said vascular surgeon Thomas Wakefield, we researchers dont know much more today about what causes blood clots in veins than our predecessors did over 100 years ago.
  • Report from Europe

    Describing the effort as a revolution in health and care information, the UK government last month announced a program intended to result in every National Health Service (NHS) patient in England having an electronic care record by the end of this decade. British Telecom (BT) was awarded a 10-year contract to set up and run the national NHS Care Records Service.
  • Acquisitions

    Bio-Imaging Technologies (Newtown, Pennsylvania) has acquired the intellectual property of privately held CapMed (Wilmington, Delaware), including the Personal Health Record (PHR) software and the patent-pending Personal HealthKey technology. Financial terms of the transaction were undisclosed.
  • Business Developments

    An FDA advisory panel gave its unanimous backing to the second in what is likely to be a lengthening line of premarket approval (PMAs) applications for drug-eluting stents (DES). The nod went to the Taxus paclitaxel-eluting coronary stent from Boston Scientific (Natick, Massachusetts).
  • Market Updates

    The American Vascular Association (AVA) reported recently that more than 10 million of the nation's vascular disease sufferers have not been diagnosed, signaling a need for increased public education on the issue. The results of the AVAs nationwide screening were announced at the 30th annual Veith Symposium International Vascular Surgery Conference in New York.
  • Product Pipeline

    A Swiss firm has developed a new non-invasive, portable device that delivers, in a proprietary manner, low-voltage stimulation impulses to the patients skeletal muscles through adhesive electrodes to improve the efficiency of even the most damaged hearts.
  • Better staff communication helps patient safety effort

    Most health care professionals would agree that patient safety continues to be a high priority for the Joint Commission on Accreditation of Health Care Organizations in Oakbrook Terrace, IL.
  • Privacy regs complicate patient communication

    The privacy regulations enacted as part of the federal Health Insurance Portability and Accountability Act (HIPAA) have caused some unforeseen complications for hospitals trying to ensure patient safety and improve communication between providers and patients, say health care professionals and legal experts.